1-7 of 7
Ruemu Birhiray
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Beyond approval: Lymphoma drugs and real-world representation (2015–2025)

Free
Sam Ranger, Maya Birhiray, Ruemu Birhiray
Journal: Blood
Blood (2025) 146 (Supplement 1): 4421.
https://doi.org/10.1182/blood-2025-4421
Published: 2025
Journal Articles

Patient-reported outcomes and actigraphy following in-class transition (iCT) from parenteral bortezomib (V) to oral ixazomib in newly diagnosed multiple myeloma (NDMM): Subgroup analysis of US MM-6 by race/ethnicity, renal function, and area income

Free
Leon Bernal-Mizrachi, Ruemu Birhiray, Murtaza Bhuriwala, Robert Rifkin, Roger Lyons, Christopher Yasenchak, Stephen Noga, Isabel Ferreira, Dasha Cherepanov, Alexandra Savell, Yunlong Xie, Saulius Girnius
Journal: Blood
Blood (2025) 146 (Supplement 1): 4004.
https://doi.org/10.1182/blood-2025-4004
Published: 2025
Journal Articles

A Systematic Review of 72 ASH Plenary and Late Breaking Abstracts for Racial Representation: A Health Equity Call to Action

Free
Maya Birhiray, Sam Ranger, Ruemu Birhiray
Journal: Blood
Blood (2024) 144 (Supplement 1): 5081.
https://doi.org/10.1182/blood-2024-205723
Published: 2024
Journal Articles

Odronextamab Monotherapy in Previously Untreated Patients with High-Risk Follicular Lymphoma (FL): Results of the Safety Lead-in of the Phase 3 Olympia-1 Study

Free
Elizabeth Brem, Wojciech Jurczak, David Belada, Jaime Perez de Oteyza, Aranzazu Alonso Alonso, Fevzi Altuntas, Michał Kwiatek, Joshua Brody, Ernesto Perez Persona, Mustafa Yenerel, Monica Tani, Jingxian Cai, Priya Deshpande, Saleem Shariff, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Ashish Risal, Ruemu Birhiray
Journal: Blood
Blood (2024) 144 (Supplement 1): 4411.
https://doi.org/10.1182/blood-2024-200080
Published: 2024
Journal Articles

In- class Transition from Parenteral Bortezomib to Oral Ixazomib in Newly Diagnosed Multiple Myeloma: Analysis of US MM-6 By Number of Treatment Cycles Received

Free
Joshua Richter, Saulius Girnius, Ruemu Birhiray, Eric Lloyd, Dasha Cherepanov, Stephen J. Noga, Isabel Nascimento-Ferreira, Robert Rifkin
Journal: Blood
Blood (2024) 144 (Supplement 1): 4757.
https://doi.org/10.1182/blood-2024-194592
Published: 2024
Journal Articles

Development and Use of an Application for the Calculation of Diversity Scores of Clinical Trials: A DRIVE Score Calculator

Free
Sam Ranger, Maya Birhiray, Ruemu Birhiray
Journal: Blood
Blood (2024) 144 (Supplement 1): 7774.
https://doi.org/10.1182/blood-2024-207744
Published: 2024
Journal Articles

CHOP-Rituximab-Interferon Therapy in Follicular Lmphoma (FL): High Remissions with Reasonable Toxicity.

Free
Ali W. Bseiso, MBBS, William G. Hocking, MD, Richard J. Mercier, MD, Bruce Krawisz, MD, Ruemu Birhiray, MD
Journal: Blood
Blood (2006) 108 (11): 4731.
https://doi.org/10.1182/blood.V108.11.4731.4731
Published: 2006